Steph Peacey, 28, was diagnosed with triple negative breast cancer in August last year after she noticed that her left breast ...

From awareness to advocacy, Karen Bonds has come full circle—turning her battle into a mission to ensure that no one fights breast cancer alone.

Steph Peacey was diagnosed with triple negative breast cancer - one of the most aggressive breast cancers - last year. She ...

Flossmoor resident and cancer survivor Ann Jackson launched the Center for Food Equity in Medicine at Flossmoor Community ...

Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...

Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.

On Saturday, Jan. 25 the entire community has been invited to rally together and buy a $15 carne guisada plate that will include a slice of cake and a drink from Christakis ...

A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...

Questions about sex and intimacy often go unanswered for people with cancer. It's a glaring problem, especially for the ...

DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...

Following a world-first approval in Japan, AstraZeneca and Daiichi Sankyo’s second antibody-drug conjugate has crossed the ...

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.